Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
ENvue Medical secures a $50 million equity facility and expands Series H investment rights to $59 million, aiming to enhance liquidity and support growth plans.
PRIVATEAug 12, 2026•about 4 hours ago
Amount Raised
$50 Million
Round Type
Series G+
Financial ServicesFinanceLending
Investors
Institutional Investor
Description
ENvue Medical entered into a $50 million committed equity facility with an institutional investor, amending its Series H preferred financing to allow for additional investment rights. This facility enables ENvue to sell common shares at its discretion, with a portion of proceeds intended for redeeming Series X Preferred Stock. The investor is also set to exercise at least $10 million of Series H rights, subject to shareholder approval. The funding aims to enhance liquidity and support ongoing growth plans.
Don't miss ENvue Medical's next move
Get an email the moment ENvue Medical raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech